Prothena Plc Stock Probability Of Bankruptcy

PRTA Stock  USD 14.53  0.75  5.44%   
Prothena Plc's chance of distress is under 6% at this time. It has tiny odds of undergoing some form of financial crunch in the near future. Chance of distress shows the probability of financial torment over the next two years of operations under current economic and market conditions. All items used in analyzing the odds of distress are taken from the Prothena balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Prothena Plc Piotroski F Score and Prothena Plc Altman Z Score analysis.
For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.
  

Prothena plc Company chance of distress Analysis

Prothena Plc's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

 = 

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Prothena Plc Probability Of Bankruptcy

    
  Less than 6%  
Most of Prothena Plc's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Prothena plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Prothena Plc probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Prothena Plc odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Prothena plc financial health.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. If investors know Prothena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prothena Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.46)
Revenue Per Share
2.482
Quarterly Revenue Growth
(0.99)
Return On Assets
(0.16)
Return On Equity
(0.23)
The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prothena Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prothena Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prothena Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Prothena Probability Of Bankruptcy Driver Correlations

Understanding the fundamental principles of building solid financial models for Prothena Plc is extremely important. It helps to project a fair market value of Prothena Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Prothena Plc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Prothena Plc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Prothena Plc's interrelated accounts and indicators.
0.980.530.780.311.0-0.92-0.790.260.960.890.90.630.52-0.70.39-0.370.420.670.67
0.980.570.620.270.98-0.91-0.680.30.890.930.810.490.49-0.570.31-0.340.560.720.69
0.530.570.280.280.54-0.64-0.610.850.570.670.490.370.84-0.470.44-0.810.460.490.71
0.780.620.280.340.75-0.67-0.870.080.870.540.920.850.43-0.860.53-0.36-0.080.320.41
0.310.270.280.340.24-0.11-0.12-0.080.210.170.2-0.060.02-0.270.350.03-0.07-0.07-0.16
1.00.980.540.750.24-0.94-0.790.290.950.90.890.640.52-0.680.38-0.40.460.70.71
-0.92-0.91-0.64-0.67-0.11-0.940.84-0.47-0.92-0.9-0.85-0.71-0.620.68-0.440.6-0.56-0.82-0.85
-0.79-0.68-0.61-0.87-0.12-0.790.84-0.46-0.92-0.68-0.93-0.93-0.720.9-0.560.71-0.15-0.53-0.73
0.260.30.850.08-0.080.29-0.47-0.460.350.480.290.390.87-0.330.53-0.890.370.410.66
0.960.890.570.870.210.95-0.92-0.920.350.850.980.790.63-0.820.46-0.510.30.620.72
0.890.930.670.540.170.9-0.9-0.680.480.850.790.490.68-0.540.37-0.450.720.840.84
0.90.810.490.920.20.89-0.85-0.930.290.980.790.830.62-0.860.46-0.470.220.560.67
0.630.490.370.85-0.060.64-0.71-0.930.390.790.490.830.62-0.840.64-0.670.010.450.63
0.520.490.840.430.020.52-0.62-0.720.870.630.680.620.62-0.60.62-0.850.370.520.78
-0.7-0.57-0.47-0.86-0.27-0.680.680.9-0.33-0.82-0.54-0.86-0.84-0.6-0.590.580.0-0.37-0.51
0.390.310.440.530.350.38-0.44-0.560.530.460.370.460.640.62-0.59-0.650.090.340.43
-0.37-0.34-0.81-0.360.03-0.40.60.71-0.89-0.51-0.45-0.47-0.67-0.850.58-0.65-0.25-0.46-0.72
0.420.560.46-0.08-0.070.46-0.56-0.150.370.30.720.220.010.370.00.09-0.250.890.74
0.670.720.490.32-0.070.7-0.82-0.530.410.620.840.560.450.52-0.370.34-0.460.890.91
0.670.690.710.41-0.160.71-0.85-0.730.660.720.840.670.630.78-0.510.43-0.720.740.91
Click cells to compare fundamentals
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition

Based on the latest financial disclosure, Prothena plc has a Probability Of Bankruptcy of 6.0%. This is 86.14% lower than that of the Biotechnology sector and 89.06% lower than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 84.94% higher than that of the company.

Prothena Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Prothena Plc's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Prothena Plc could also be used in its relative valuation, which is a method of valuing Prothena Plc by comparing valuation metrics of similar companies.
Prothena Plc is currently under evaluation in probability of bankruptcy category among its peers.

Prothena Plc ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Prothena Plc's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Prothena Plc's managers, analysts, and investors.
Environmental
Governance
Social

Prothena Fundamentals

About Prothena Plc Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Prothena plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Prothena Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Prothena plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Prothena plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Prothena Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prothena Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prothena Plc Stock:
Check out Prothena Plc Piotroski F Score and Prothena Plc Altman Z Score analysis.
For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. If investors know Prothena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prothena Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.46)
Revenue Per Share
2.482
Quarterly Revenue Growth
(0.99)
Return On Assets
(0.16)
Return On Equity
(0.23)
The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prothena Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prothena Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prothena Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.